12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Fri, 28 Aug 2026 07:53:20 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Cache-Control: no-cache, no-store, must-revalidate [6] => Set-Cookie: UpalLiveSession=eyJpdiI6ImwzRGFtVjV4VWkrUm94cGdIMlZJR2c9PSIsInZhbHVlIjoiR3hvdW1sTFBOXC9oY3U2cWpsSGFhb0laQmdBNTRYTEg3SjR5T1kxN3VvaTZ6bmhJZHNON2JBM3Qya3A0MnhyUnpvQ2cydEhaVGhscWYrZTN1VzF5THl3PT0iLCJtYWMiOiIwNjAzMzlhZTUyZWQwN2FkZjY2MTcwMzAwMDBiNjZlNWRiMmM4YjdiNTNhNjYwM2IxN2FkM2Y1YjlmMjk4NThjIn0%3D; expires=Mon, 27-Aug-2029 07:53:20 GMT; Max-Age=94608000; path=/; HttpOnly [7] => x-frame-options: SAMEORIGIN [8] => x-content-type-options: nosniff [9] => x-xss-protection: 1; mode=block [10] => referrer-policy: strict-origin-when-cross-origin [11] => permissions-policy: geolocation=(), microphone=(), camera=() [12] => content-security-policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [13] => Server: cloudflare [14] => x-robots-tag: noindex, nofollow, nosnippet, noarchive [15] => strict-transport-security: max-age=31536000; includeSubDomains; preload [16] => expires: Sat, 29 Aug 2026 07:53:19 GMT [17] => vary: Accept-Encoding [18] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [19] => cf-cache-status: DYNAMIC [20] => Speculation-Rules: "/cdn-cgi/speculation" [21] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [22] => Server-Timing: cfEdge;dur=14,cfOrigin;dur=417 [23] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=rmZ3bZAHXZm2fY%2Bug%2FrvZsrcbeJ2QLV%2FaXpbPkkLdSvpe9KSqLpZb%2F1SM6yU1f5Sms0LprqLLDMTfoKn4jLpALnSxL4uYIBiMD0NcuZzu56Kdwdx2WGtEd3W4k57SgR2Elk%3D"}]} [24] => CF-RAY: a321bdd9f8506584-SIN [25] => alt-svc: h3=":443"; ma=86400 ) 789

一项上周在美国发表的研究显示，跨性别男性在接受睾丸酮贺尔蒙疗程1年之后，他们卵巢似乎尚有功能，这对希望生育的跨性别男性来说，或许是个喜讯。

跨性别男性是指天生是女性但自我认同是男性的人，他们不一定接受了性别重置手术（即变性手术），但当中不少人会注射睾丸酮，以令自己的身体更男性化。

以色列特拉维夫索拉斯基医疗中心对52名17岁至40岁、接受了1年睾丸酮注射的跨性别男性进行研究，并审视了其中32人的完整研究结果，发现他们体内的抗穆氏管贺尔蒙虽然下跌，但仍处于能够生育的正常水平，显示他们卵巢功能或仍处于可以生育的程度。

抗穆氏管贺尔蒙是卵巢中卵泡库存量一种指标，医生会用此评估的卵子剩余供应量。

研究的领导人格林曼称这次是首个同类研究结果，她说：“这个资讯，对于希望有自己小朋友的跨性别男性和他们的伴侣来说很重要。”

---

// // // //